Blue Prism shares soar after revenues jump 83%
saw sales almost double during 2019 according to its final results released on Thursday.
The robotic process automation software company reported revenues of £101 million, an 83% increase from £55.2 million in the prior year, with recurring licence revenue accounting for 96% of the revenues.
The company said that upselling in the second half of 2019 saw record quarters across each of its key geographies, and closed the year end with 1677 customers, up from 992 in the previous year.
Blue Prism widened its adjusted loss to £71.9 million, up from £21.6 million and had negative operating cash flow of £57.9 million, up from £5.4 million.
The company however revised its profit guidance for 2020 upwards and said that the investments it made during 2018 and 2019 were paying off.
Shares jumped 22.28% higher to £15.04 during Thursday morning trading
Executive Chairman Jason Kingdon commented: "We have made excellent progress in operations and financial performance during 2019, with revenue and MRR exceeding the levels guided to in our trading update in November.”
“Our enterprise customer base has grown significantly and our track record of upselling remains very encouraging. This upselling capability generated record quarters in each of our key geographies in the second half of the year, with increases in both volume and sizes of upsells.”
“The increasing momentum we have seen as the year progressed reflects the investments we made during 2018 and we expect this to continue, as our 2019 investment programme begins to show returns.”
“Following this investment the business is well positioned to take advantage of the significant opportunity its enterprise focused RPA represents. Blue Prism's differentiated role as the partner for enterprise grade RPA is increasingly demonstrated by our high quality customer base and this underpins our confidence in the future."
Follow News & Updates from Blue Prism Group here:
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.